CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ): Form 8-K filed 2026-11-13
- Accepted by EDGAR
- 2026-11-13 16:05 ET
- Event date
- 2026-11-10
- Accession no.
- 0001477932-26-006933
- Original filing
- SEC EDGAR filing index
AI summary of the filing text. It can contain mistakes; the original filing is authoritative.
Creative Medical Technology receives Nasdaq minimum bid price noncompliance notice
Creative Medical Technology received a Nasdaq notice that it was not in compliance with the minimum bid price rule after its common stock closed below $1.00 per share for 30 consecutive business days. The notice has no immediate impact on its listing, and the Company has until May 10, 2027, to regain compliance.
- The Company received Nasdaq's notice on November 10, 2026.
- Its closing bid price was below $1.00 per share for 30 consecutive business days.
- The Company has a 180 day grace period, until May 10, 2027, to regain compliance.
- Compliance requires a closing bid price of $1.00 per share or more for a minimum of ten consecutive business days.
listing notice
Items reported
- Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
The company received notice from its exchange that it does not satisfy a continued listing rule (for example a minimum bid price or filing requirement), or it decided to delist or transfer its listing. - Item 9.01: Financial Statements and Exhibits
Lists the financial statements, pro forma information and exhibits filed with the report. It almost always accompanies another Item and is rarely news on its own.
Documents
| Type | Description | Document |
|---|---|---|
| 8-K | FORM 8-K | celz_8k.htm |
The summary above was generated by AI from the filing text and checked automatically against it. Read the original documents on SEC EDGAR. How to read an 8-K.